Literature DB >> 1711074

Comparison of structural requirements for interaction of the same peptide with I-Ek and I-Ed molecules in the activation of MHC class II-restricted T cells.

J Leighton1, A Sette, J Sidney, E Appella, C Ehrhardt, S Fuchs, L Adorini.   

Abstract

We have analyzed the interaction of the hen egg-white lysozyme (HEL) peptide 107-116 with the MHC class II molecule I-Ek, using truncated and single residue substitution analogues to measure activation of I-Ek-restricted, 107-116-specific T cell hybridomas and competition for Ag presentation by I-Ek molecules. These results have been compared with previous findings on the interaction of the same peptide with the I-Ed molecule. Stimulation of T cell hybridomas by truncated peptides defines the sequence 108-116 as the minimum epitope necessary for activation of both I-Ek- and I-Ed-restricted T cell hybridomas. Substitution analysis pinpoints three residues (V109, A110, and K116) in the sequence 108-116 as being critical for binding to I-Ek molecules and demonstrates the involvement of most other residues in recognition by T cells. Results previously obtained for binding of HEL 107-116 to I-Ed molecules indicated that peptide residues R112, R114, and K116 were critical for interaction with I-Ed. Comparison of these results indicates a difference in the likely MHC contact residues between the HEL sequence 108-116 and I-Ed or I-Ek molecules, suggesting that the same HEL peptide assumes a different conformation in the binding site of these two MHC molecules. This in turn affects residues interacting with the specific T cell receptor. According to the hypothetical tridimensional structure predicted for class II molecules, the difference in MHC contact residues observed within the sequence 108-116 can be related to polymorphic amino acids in the binding site of I-Ek and I-Ed molecules. A search through published binding data for a common pattern in this and other I-Ek-binding peptides has permitted us to derive a possible motif for predicting peptide binding to I-Ek molecules. This putative motif was tested by determining binding to I-Ek of an unbiased panel of about 150 synthetic peptides. Binding data indeed demonstrate the presence of this motif in the majority of good binders to I-Ek molecules.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711074

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Periodic variation in side-chain polarities of T-cell antigenic peptides correlates with their structure and activity.

Authors:  J L Cornette; H Margalit; J A Berzofsky; C DeLisi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

2.  Enhancement of peptide antigen presentation by a second peptide.

Authors:  A I de Kroon; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

3.  Induction of murine thyroiditis by a non dominant E(k)-restricted peptide of human thyroglobulin.

Authors:  Evangelos Karras; George Carayanniotis; Peggy Lymberi
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

Review 4.  The optimization of helper T lymphocyte (HTL) function in vaccine development.

Authors:  J Alexander; J Fikes; S Hoffman; E Franke; J Sacci; E Appella; F V Chisari; L G Guidotti; R W Chesnut; B Livingston; A Sette
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

5.  Distinct genetic pattern of mouse susceptibility to thyroiditis induced by a novel thyroglobulin peptide.

Authors:  G Carayanniotis; E Chronopoulou; V P Rao
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

6.  Mapping of thyroglobulin epitopes: presentation of a 9mer pathogenic peptide by different mouse MHC class II isotypes.

Authors:  V P Rao; B Balasa; G Carayanniotis
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

7.  Major histocompatibility complex non-restricted presentation to CD4+ T lymphocytes of Mycobacterium leprae heat-shock protein 65 antigen by macrophages transfected with the mycobacterial gene.

Authors:  C L Silva; K Lukacs; D B Lowrie
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

8.  Identification of an I-Ed-restricted T-cell epitope of Escherichia coli outer membrane protein F.

Authors:  Kristina M Williams; Elmer C Bigley
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

9.  Comparison of peptides bound to spleen and thymus class II.

Authors:  P Marrack; L Ignatowicz; J W Kappler; J Boymel; J H Freed
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

10.  Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.

Authors:  J C Guéry; A Sette; J Leighton; A Dragomir; L Adorini
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.